Evidence map›Paper›PMID 28828372›Full record

ReviewAnnals of translational medicine2017

High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure.

Jean-Pierre Frat, Rémi Coudroy, Nicolas Marjanovic, Arnaud W Thille

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Annals of translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04998383 (HVNI vs Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure), which is not on this map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04998383 naunknown statusnot on this mapstarted 2021, after this paper: background citation

HVNI vs Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure

TypeinterventionalSponsorAssiut UniversityRan2021 to 2022Enrolled100ConditionsComparison Between HVNI vs Noninvasive Ventilation for Acute Hypercapnic Respiratory FailureArmsHVNI
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Early Prediction of High-flow Nasal Cannula Failure Using Pediatric-modified HACOR Score in Children with Acute Hypoxemic Respiratory Distress: A Prospective Observational Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jean-Pierre FratCHU de Poitiers, Réanimation Médicale, Poitiers, France.
Rémi CoudroyCHU de Poitiers, Réanimation Médicale, Poitiers, France.
Nicolas MarjanovicINSERM, CIC-1402, équipe 5 ALIVE, Poitiers, France.
Arnaud W ThilleCHU de Poitiers, Réanimation Médicale, Poitiers, France.
Centre Hospitalier Universitaire de Poitiers · FRUniversité de Poitiers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-flow nasal cannula (HFNC) oxygen therapy is a recent technique delivering a high flow of heated and humidified gas. HFNC is simpler to use and apply than noninvasive ventilation (NIV) and appears to be a good alternative treatment for hypoxemic acute respiratory failure (ARF). HFNC is better tolerated than NIV, delivers high fraction of inspired oxygen (FiO

Indexed as

acute respiratory failure (ARF)High-flow oxygen therapynoninvasive ventilation (NIV)

Identifiers

PMID28828372
PMCPMC5537116
OpenAlexW2738922850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.